(1 - 6 von 8
)
Experienced Venture Capitalist/Pharma Manager Joins Apeiron`s...
www.firmenpresse.de
Commenting on the appointment of Mr. Burgermeister, Hans Loibner, CEO of Apeiron, stated:
Paladin Labs Signs Agreement for Novel Biologic to Treat Neuroblastoma
www.finanznachrichten.de
Paladin is well positioned to make APN311 a success in its territories", said Hans Loibner, President and CEO of Apeiron Biologics. (1) Neuroblastoma Canada,
Oncology Alliance: Apeiron, CCRI and SIOPEN join forces against ...
www.bionity.com
Dr. Hans Loibner, CEO of Apeiron, commented on the successful completion of the agreement: "This novel form of collaboration with CCRI and SIOPEN is a milestone for Apeiron. These non-profit organizations have ...
sortiert nach Relevanz / Datum